
Jan 11 (Reuters) - Day One Biopharmaceuticals Inc DAWN.O:
DAY ONE ANNOUNCES PRELIMINARY 2025 OJEMDA™ NET PRODUCT REVENUE AND PROVIDES 2026 NET PRODUCT REVENUE GUIDANCE
DAY ONE BIOPHARMACEUTICALS INC - OJEMDA 2026 U.S. NET PRODUCT REVENUE PROJECTED TO BE $225 - $250 MILLION